News & Media
News Updates
Understanding drug test detection times is essential when choosing a testing method that aligns with your organization’s safety and compliance goals. While some methods identify drug use days after the
With over 450 accounts across 24 countries, INBS continues to advance the evolution of drug screening technology NEW YORK, June 25, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the
Employers are rethinking their approach to drug screening. Traditional tests, like urine and saliva, have been the standard for years, but they have logistical challenges and privacy concerns. A newer
NEW YORK, June 18, 2025 — Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that Managed Waste Service
Many drug testing programs rely on urine or saliva collection, often chosen because they appear inexpensive. But what looks affordable on paper can become costly, especially once you factor in
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more than 1,500 tests in 2024 alone Company continues to actively
Accuracy isn’t the only factor that matters when selecting a drug test for your work. You need a testing solution that balances reliability with convenience, protects employee privacy, and ensures your
Random drug testing is vital to safety and compliance policies in many industries, from construction and manufacturing to transport and logistics. But while the aim is clear: preventing drug-related incidents
INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450
Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches NEW YORK, May 19, 2025 –
As workplace safety and compliance standards rise, more organizations are evaluating how drug testing is conducted and when it can detect use. One of the most common questions from health
Company surpasses 450 accounts across 24 countries as global demand for fingerprint drug testing surges NEW YORK, May 15, 2025 – Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the
Media Contact
For media enquiries, please contact marketing@ibs.inc.
Featured Media
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Our innovative technology has been featured worldwide in leading news outlets and media platforms.
The Intelligent Fingerprinting Drug Screening System is revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis.
